register

News & Trends - Pharmaceuticals

Why ESG is a critical focus for Sanofi and Philips: Leaders talk the journey to meaningful impact

Health Industry Hub | May 8, 2023 |

ESG (Environmental, Social, and Governance) has become increasingly significant in the pharmaceutical and medtech industries for several reasons.

Rebekah Cassidy, Deputy Head of Corporate Affairs, Sanofi ANZ and Sarah Al-Hashimi, Corporate Communications Leader, Philips ANZ joined Health Industry Hub to discuss how the companies have prioritised ESG initiatives as a way to improve their overall sustainability and address the voices of internal and external stakeholders.

“People are searching for purpose. It’s really hard for our employees to separate their personal lives from professional lives. People come to work with expectations and values when it comes to social issues. They want their employers to mirror what they care about and involve them in the process, especially through grassroot initiatives at Philips,” said Sarah.

Bek added “Regarding regulatory interest in ESG, in particular environmental impact, the big thing that I would say is that your ESG programs are not PR or marketing programs. There needs to be assurance that the claims that every company is making are true and correct, and confidence that the independent assurance is in place as well. That is a really big focus for Sanofi.”

Australia has no overarching source of ESG regulation or framework. Bek and Sarah addressed the reasons policy makers should drive a national approach and how companies like Sanofi and Philips are contributing to this journey.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.

The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. To subscribe, please click here and visit T&Cs here.


News & Trends - MedTech & Diagnostics

Aussie medtech forges ahead, making inroads with new technology

Aussie medtech forges ahead, making inroads with new technology

Health Industry Hub | February 23, 2024 |

MedTech & Diagnostics News: Adelaide-based medical technology firm, LBT Innovations has successfully delivered its cutting-edge Automated Plate Assessment System (APAS) […]

More


News & Trends - Pharmaceuticals

Is the imposed PBS funding cap driving the migraine medicines shortage?

Is the imposed PBS funding cap driving the migraine medicines shortage?

Health Industry Hub | February 23, 2024 |

Pharma News: Australia finds itself grappling with an unparalleled shortage of migraine prevention medicines, leaving a significant impact on the […]

More


News & Trends - Pharmaceuticals

MSAC rejects Janssen's CAR T therapy despite clinical superiority, citing need for 'substantial price reduction'

MSAC rejects Janssen’s CAR T therapy despite clinical superiority, citing need for ‘substantial price reduction’

Health Industry Hub | February 23, 2024 |

Pharma News: The Medical Services Advisory Committee (MSAC) has deferred its decision on whether Janssen’s CAR T-cell therapy Carvykti (cilta-cel) […]

More


News & Trends - Pharmaceuticals

Gedeon Richter secures first endometriosis treatment in over a decade, with experts pushing for extension of NAPE

Gedeon Richter secures first endometriosis treatment in over a decade, with experts pushing for extension of NAPE

Health Industry Hub | February 23, 2024 |

Pharma News: The Therapeutic Goods Administration (TGA) has granted approval for the first endometriosis treatment in 13 years. Gedeon Richter […]

More


This content is copyright protected. Please subscribe to gain access.